Inflamm Bowel Dis. 2012 Apr;18(4):793-4. doi: 10.1002/ibd.21773. Epub 2011 May 3.

Adalimumab for ulcerative colitis: a little is better than none?

Danese S.

Source

IBD Center Istituto Clinico Humanitas, Rozzano Milan, Italy.

Comment on

Gut. 2011 Jun;60(6):780-7.

PMID:: 21542069; [PubMed - in process]

Publication Types

Comment

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. [World J Gastroenterol. 2007]
Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.
Peyrin-Biroulet L, Laclotte C, Roblin X, Bigard MA. World J Gastroenterol. 2007 Apr 28; 13(16):2328-32.
Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis. [J Crohns Colitis. 2012]
Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis.
McDermott E, Murphy S, Keegan D, O'Donoghue D, Mulcahy H, Doherty G. J Crohns Colitis. 2012 Apr 18; . Epub 2012 Apr 18.
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience. [Aliment Pharmacol Ther. 2008]
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.
Oussalah A, Laclotte C, Chevaux JB, Bensenane M, Babouri A, Serre AA, Boucekkine T, Roblin X, Bigard MA, Peyrin-Biroulet L. Aliment Pharmacol Ther. 2008 Oct 15; 28(8):966-72. Epub 2008 Jul 24.
Review Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. [BioDrugs. 2010]
Review Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F, Portela F. BioDrugs. 2010 Dec 14; 24 Suppl 1:3-14.
Review Adalimumab in ulcerative colitis: hypes and hopes. [Expert Opin Biol Ther. 2011]
Review Adalimumab in ulcerative colitis: hypes and hopes.
Fiorino G, Peyrin-Biroulet L, Repici A, Malesci A, Danese S. Expert Opin Biol Ther. 2011 Jan; 11(1):109-16.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Adalimumab for ulcerative colitis: a little is better than none?
Adalimumab for ulcerative colitis: a little is better than none?
Inflamm Bowel Dis. 2012 Apr ;18(4):793-4. doi: 10.1002/ibd.21773. Epub 2011 May 3 .

PubMed
SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
Mov Disord. 2011 Aug 15 ;26(10):1881-6. doi: 10.1002/mds.23750. Epub 2011 May 3 .

PubMed
Factors associated with differential response to online cognitive behavioural th...
Factors associated with differential response to online cognitive behavioural therapy.
Soc Psychiatry Psychiatr Epidemiol. 2012 May ;47(5):827-33. Epub 2011 May 4 .

PubMed
Longitudinal study of human papillomavirus infection of the female urogenital tr...
Longitudinal study of human papillomavirus infection of the female urogenital tract by in situ hybridization.
Arch Pathol Lab Med. 1990 Feb ;114(2):155-9.

PubMed
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalenc...
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Eur J Clin Microbiol Infect Dis. 2011 Nov ;30(11):1355-63. Epub 2011 May 4 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Adalimumab for ulcerative colitis: a little is better than none?

Source

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information